These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2037539)

  • 1. Bronchial penetration of ofloxacin after single and multiple oral dosage.
    Davey PG; Precious E; Winter J
    J Antimicrob Chemother; 1991 Mar; 27(3):335-41. PubMed ID: 2037539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The penetration of ofloxacin into bronchial secretions.
    Symonds J; Javaid A; Bone M; Turner A
    J Antimicrob Chemother; 1988 Sep; 22 Suppl C():91-5. PubMed ID: 3182469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ofloxacin concentrations in tissues involved in respiratory tract infections.
    Perea EJ
    J Antimicrob Chemother; 1990 Nov; 26 Suppl D():55-60. PubMed ID: 2286591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diffusion of an orally administered single dose of ofloxacin into human bronchial mucus].
    Morel C; Malbruny B; Vergnaud M; Benard Y; Monrocq N
    Pathol Biol (Paris); 1986 May; 34(5):353-6. PubMed ID: 3534705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penetration of ofloxacin into bronchial secretions.
    Symonds J; Bone M; Turner A; Javaid A
    Drugs; 1987; 34 Suppl 1():33-6. PubMed ID: 3481325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concentrations of trovafloxacin in bronchial mucosa, epithelial lining fluid, alveolar macrophages and serum after administration of single or multiple oral doses to patients undergoing fibre-optic bronchoscopy.
    Andrews JM; Honeybourne D; Brenwald NP; Bannerjee D; Iredale M; Cunningham B; Wise R
    J Antimicrob Chemother; 1997 Jun; 39(6):797-802. PubMed ID: 9222050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brodimoprim concentrations in bronchial mucosa, bronchial secretions and middle ear effusions.
    Scaglione F; Cogo R; Pintucci JP; Demartini G; Dugnani S; Maccarinelli G; Fraschini F
    J Chemother; 1993 Dec; 5(6):490-3. PubMed ID: 8195843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral ofloxacin once daily and doxycycline in the treatment of acute exacerbations of chronic bronchitis.
    Punakivi L; Keistinen T; Backman R; Lehtipuu AL; Saarelainen P; Vilkka V; Veneskoski T; Ammälä K; Aro A
    Scand J Infect Dis Suppl; 1990; 68():41-5. PubMed ID: 2218421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penetration of amoxycillin/clavulanic acid into bronchial mucosa with different dosing regimens.
    Gould IM; Harvey G; Golder D; Reid TM; Watt SJ; Friend JA; Legge JS; Douglas JG
    Thorax; 1994 Oct; 49(10):999-1001. PubMed ID: 7974318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penetration of lomefloxacin into bronchial secretions following single and multiple oral administration.
    Bergogne-Bérézin E; Muller-Serieys C; Kafé H
    Am J Med; 1992 Apr; 92(4A):8S-11S. PubMed ID: 1316076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentrations of ceftibuten in bronchial secretions.
    Scaglione F; Triscari F; Demartini G; Arcidiacono M; Cocuzza C; Fraschini F
    Chemotherapy; 1995; 41(4):229-33. PubMed ID: 7555201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of gatifloxacin after a single oral dose in healthy young adult subjects and adult patients with chronic bronchitis, with a comparison of drug concentrations obtained by bronchoscopic microsampling and bronchoalveolar lavage.
    Kikuchi J; Yamazaki K; Kikuchi E; Ishizaka A; Nishimura M
    Clin Ther; 2007 Jan; 29(1):123-30. PubMed ID: 17379052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefepime concentrations in bronchial mucosa and serum following a single 2 gram intravenous dose.
    Chadha D; Wise R; Baldwin DR; Andrews JM; Ashby JP; Honeybourne D
    J Antimicrob Chemother; 1990 Jun; 25(6):959-63. PubMed ID: 2196260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary penetration of ceftazidime.
    Cazzola M; Gabriella Matera M; Polverino M; Santangelo G; De Franchis I; Rossi F
    J Chemother; 1995 Feb; 7(1):50-4. PubMed ID: 7629560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penetration of cefaclor into bronchial mucosa.
    Marlin GE; Nicholls AJ; Funnell GR; Bradbury R
    Thorax; 1984 Nov; 39(11):813-7. PubMed ID: 6505987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the effects of ambroxol on the ofloxacin concentrations in bronchial tissues in COPD patients with infectious exacerbation.
    Paganin F; Bouvet O; Chanez P; Fabre D; Galtier M; Godard P; Michel FB; Bressolle F
    Biopharm Drug Dispos; 1995 Jul; 16(5):393-401. PubMed ID: 8527688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of experience with ofloxacin in respiratory tract infection.
    Ball P
    Scand J Infect Dis Suppl; 1990; 68():56-63. PubMed ID: 2218424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentrations of cefpodoxime in serum and bronchial mucosal biopsies.
    Baldwin DR; Wise R; Andrews JM; Honeybourne D
    J Antimicrob Chemother; 1992 Jul; 30(1):67-71. PubMed ID: 1429338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penetration of levofloxacin into paranasal sinuses mucosa of patients with chronic rhinosinusitis after a single 500 mg oral dose.
    Pea F; Marioni G; Pavan F; Staffieri C; Bottin R; Staffieri A; Furlanut M
    Pharmacol Res; 2007 Jan; 55(1):38-41. PubMed ID: 17092740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penetration of ampicillin into human bronchial secretions.
    Bergogne-Berezin E; Berthelot G; Kafe H; Morel C
    Infection; 1979; 7 Suppl 5():S463-4. PubMed ID: 511358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.